About this trial
ICU mortality indicates the severity of disease, healthcare quality, and the efficacy of interventions. The severity scores are tools to predict the risk of mortality in the ICU, and the APACHE II score is frequently used for this purpose. However, studies validating the score in Colombia are limited. There is uncertainty about the precision and discrimination capacity of the APACHE II score in a population that varies from the original, with varying diseases, and in a different timeline. The investigators determined to evaluate: 1. Evaluate the rate of mortality in the ICU by type of disease and type of admission. 2. The factors associated with mortality. 3. Validate the performance of the APACHE II score as a predictor of mortality.
Eligibility criteria
Qualifiers
All adult patients older than 18 admitted to the intensive care unit during the study period.
Disqualifiers
Patients admitted for intermediate care (low therapeutic intervention with a TISS [Therapeutic Intervention Scoring System] - 28 score below 20 points). Patients derived to other institutions.
Trial design
Treatments tested in this trial
- Exposure factors